Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Dynatronics Cp (NQ: DYNT )

1.556 +0.046 (+3.05%)
Streaming Delayed Price Updated: 3:18 PM EDT, Mar 29, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Dynatronics Cp

< Previous 1 2 Next >
Dynatronics's Return On Capital Employed Insights
 
Via Benzinga
Dynatronics's Earnings Outlook
 
Via Benzinga
Dynatronics's Return On Capital Employed Overview
 
Via Benzinga
Dynatronics's Return On Capital Employed Insights
Benzinga Pro data, Dynatronics (NASDAQ:DYNT) reported Q4 sales of $11.19 million. Earnings fell to a loss of $1.57 million, resulting in a 6.39% decrease from last quarter. 
Via Benzinga
Recap: Dynatronics Q4 Earnings
Dynatronics (NASDAQ:DYNT) reported its Q4 earnings results on Thursday, September 22, 2022 at 07:30 AM. Here's what investors need to know about the announcement. 
Via Benzinga
Earnings Scheduled For September 22, 2022
Companies Reporting Before The Bell • iHuman (NYSE:IH) is expected to report earnings for its second quarter. 
Via Benzinga
Dynatronics: Q3 Earnings Insights
Dynatronics (NASDAQ:DYNT) reported its Q3 earnings results on Thursday, May 12, 2022 at 07:30 AM. Here's what investors need to know about the announcement. 
Via Benzinga
Recap: Dynatronics Q2 Earnings
  Dynatronics (NASDAQ:DYNT) reported its Q2 earnings results on Thursday, February 10, 2022 at 07:30 AM. Here's what investors need to know about the announcement. 
Via Benzinga
Earnings Scheduled For February 10, 2022
Companies Reporting Before The Bell • Canada Goose Hldgs (NYSE:GOOS) is projected to report quarterly earnings at $1.46 per share on revenue of $584.49 million. 
Via Benzinga
Earnings Scheduled For November 11, 2021
Companies Reporting Before The Bell • NICE (NASDAQ:NICE) is likely to report quarterly earnings at $1.58 per share on revenue of $465.75 million. • Reshape... 
Via Benzinga
Earnings Preview For Dynatronics
Dynatronics (NASDAQ:DYNT) is set to give its latest quarterly earnings report on Thursday, 2022-09-22. Here's what investors need to know before the announcement. Analysts estimate that Dynatronics... 
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
Pre-market stock movers are the hot topic this morning as we cover all the latest news sending shares higher and lower on Monday! 
Via InvestorPlace
Benzinga's Top Ratings Upgrades, Downgrades For July 27, 2022
  
Via Benzinga
Overview Of Value Stocks In The Healthcare Sector
Understanding Value Stocks A value stock is traditionally defined in terms of how investors in the marketplace are valuing that company's future growth prospects. Low P/E... 
Via Benzinga
Stocks That Hit 52-Week Lows On Friday
During Friday's trading, 54 companies set new 52-week lows. Things to Consider About Today's 52-Week Lows: The largest company by market cap to hit a new 52-week... 
Via Benzinga
Stocks That Hit 52-Week Lows On Wednesday
During Wednesday's session, 18 companies made new 52-week lows. Noteable 52-Week Lows: PayPal Holdings (NASDAQ:PYPL) is the largest company in terms of market... 
Via Benzinga
5 Value Stocks In The Healthcare Sector
Understanding Value Stocks A value stock traditionally has a lower price when compared to stock prices of companies in the same industry. This indicates that the company may be... 
Via Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
Gainers Tempest Therapeutics (NASDAQ:TPST... 
Via Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
Gainers EyePoint Pharmaceuticals (NASDAQ:EYPT) stock increased by 44.96% to $20.31 during Monday's pre-market session. The market value of their outstanding shares is... 
Via Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Gainers ADMA Biologics (NASDAQ:ADMA) shares moved upwards by 11.42% to $1.56 during Thursday's pre-market session. The market value of their outstanding shares is at $... 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Gainers Viridian Therapeutics (NASDAQ:VRDN) stock rose 22.49% to $19.17 during Tuesday's pre-market session. The company's market cap stands at $331.8 million. Inhibrx (... 
Via Benzinga
Dynatronics Guides Annual Revenue Ahead Of Wall Street Estimates
Dynatronics Corporation (NASDAQ: DYNT) has reported Q4 FY21 EPS of $0.16, surpassing the consensus estimate of $0.03 and a turnaround from EPS loss of $(0.18) a year... 
Via Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Gainers TransCode Therapeutics (NASDAQ:RNAZ) shares increased by 23.66% to $3.24 during Thursday's pre-market session. The company's market cap stands at $41.8... 
Via Benzinga
Earnings Scheduled For September 23, 2021
Companies Reporting Before The Bell • Rite Aid (NYSE:RAD) is projected to report quarterly loss at $0.42 per share on revenue of $6.25 billion. • Dynatronics (... 
Via Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
Gainers Regencell Bioscience (NASDAQ: 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Gainers Progenity (NASDAQ:PROG) stock rose 20.19% to $1.13 during Tuesday's pre-market session. The company's market cap stands at $134.9 million. aTyr Pharma (... 
Via Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
Gainers Hims & Hers Health (NYSE:HIMS)... 
Via Benzinga
Dynatronics Stock Is Trading Higher On Interim Q4 Sales Beating Wall Street Consensus
Dynatronics Corporation (NASDAQ: DYNT) is trading higher in the premarket session after it announced preliminary Q4 FY21 sales of around $12.1 million, ahead of the... 
Via Benzinga
85 Biggest Movers From Yesterday
Gainers Fulcrum Therapeutics, Inc. (NASDAQ: FULC) jumped 125.3% to close at $18.77 on Tuesday after the company announced positive interim results from the Phase 1 trial with FTX... 
Via Benzinga
54 Stocks Moving In Tuesday's Mid-Day Session
Gainers Fulcrum Therapeutics, Inc. (NASDAQ: FULC) climbed 79.3% to $14.93 after the company announced positive interim results from the Phase 1 trial with FTX-6058 in healthy... 
Via Benzinga
< Previous 1 2 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.